Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 230,352,512 papers from all fields of science
Search
Sign In
Create Free Account
CM 101
Known as:
CM-101
, CM101
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
ZD0101
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Inhibition of Oncogenic Transcription Factor REL by the Natural Product Derivative Calafianin Monomer 101 Induces Proliferation Arrest and Apoptosis in Human B-Lymphoma Cell Lines
Alan T Yeo
,
Spandan Chennamadhavuni
,
A. Whitty
,
J. Porco
,
T. Gilmore
Molecules
2015
Corpus ID: 17647920
Increased activity of transcription factor NF-κB has been implicated in many B-cell lymphomas. We investigated effects of…
Expand
2009
2009
Study on the Effect of Sodium Dodecyl Sulfate on the Cloud Point of Nonionic Surfactant CM101
Xiao Yong
2009
Corpus ID: 101444935
Effect of the anionic surfactant sodium dodecyl sulfate(SDS) on the cloud point of nonionic surfactant CM101 was studied,and the…
Expand
2005
2005
Soluble E-selectin in cancer patients as a marker of the therapeutic efficacy of CM101, a tumor-inhibiting anti-neovascularization agent, evaluated in phase I clinical trial
B. Wamil
,
G. Thurman
,
+5 authors
C. Hellerqvist
Journal of Cancer Research and Clinical Oncology
2005
Corpus ID: 30926947
A polysaccharide toxin, GBS toxin, is produced by group BStreptococcus (GBS) isolates from neonates who died of “early-onset…
Expand
2000
2000
CM101 treatment overrides tumor-induced immunoprivilege leading to apoptosis.
F. Yakes
,
B. Wamil
,
+4 authors
H. Y
Cancer Research
2000
Corpus ID: 11249127
CM101, a bacterial polysaccharide exotoxin produced by group B Streptococcus (GBS), also referred to as GBS toxin, has been shown…
Expand
1998
1998
“CM101 — An Anti-Pathoangiogenic Agent: Pre-Clinical and Clinical Experiences”
C. Hellerqvist
1998
Corpus ID: 68488480
The pathophysiology of Group B Streptococcal (GBS) disease depends on the age of the neonate infected. Neonates infected at birth…
Expand
1998
1998
Improvement of wound healing with CM101 / GBS toxin
R. Abramovitch
,
G. C. Hellerqvist
,
M. Neeman
,
D. Wamil
1998
Corpus ID: 79618036
1997
1997
Phase I study of the antineovascularization drug CM101.
R. Devore
,
C. Hellerqvist
,
+10 authors
D. Johnson
Clinical Cancer Research
1997
Corpus ID: 9244953
CM101 is a bacterial polysaccharide that induces neovascular inflammation in malignant tumors. Fifteen patients with refractory…
Expand
1996
1996
Modulation of lnterleukin‐12 mRNA Expression in Leukocytes of Cancer Patients Treated with CM101
C. Hellerqvist
,
R. Lloyd
,
E. Wang
,
S. Bardhan
Annals of the New York Academy of Sciences
1996
Corpus ID: 36459916
1989
1989
[Effect of a protein-bound polysaccharide, PSK, on human hemopoietic progenitors].
K. Tsuji
,
M. Takagi
,
+5 authors
T. Akabane
Nihon Ketsueki Gakkai zasshi : journal of Japan…
1989
Corpus ID: 23848985
Using in vitro clonal culture assays, we investigated the effects of PSK, a protein-bound polysaccharide derived from the…
Expand
Review
1948
Review
1948
Book Reviews
M. Yoder
Pharmaceutical Research
1948
Corpus ID: 4752830
Angiogenesis in Health and Disease: Basic Mechanisms and mediating endothelial transcriptional responses to hypoxia were…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE